Genmabs kræftmiddel med fremgang i USA: Salg stiger 10 pct. i januar

Biotekselskabet Genmab fortsætter med at kunne se salget af kræftmidlet Darzalex vokse på det amerikanske marked. Darzalex, der er godkendt til behandling af knoglemarvskræft, solgte fo …

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

You must be logged in to post a comment.

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and
%d bloggers like this: